FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

Market cap $4.72M

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

About: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

Employees: 13

Healthcare Drug Manufacturers - General

Financial journalist opinion

Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market

BOULDER, Colo. , Feb. 25, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) ("Fresh Tracks" or the "Company") announced today an update on its previously announced, planned dissolution and its process for distributing cash to its stockholders.

Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market

Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution

BOULDER, Colo., Jan. 27, 2025 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) ("Fresh Tracks" or "the Company") announced today that the Court of Chancery of the State of Delaware ("the Court") has granted the consent judgment agreed to by the Company in the case of David R. McAvoy versus Fresh Tracks, as a result of which the Court has appointed Albert N. Marchio II, Chief Executive Officer and Chief Financial Officer of Fresh Tracks, as the custodian of Fresh Tracks pursuant to 8 Del. C. § 226 with a directive to dissolve the Company and wind up its affairs. Fresh Tracks currently anticipates it will complete the dissolution and make a distribution of between $0.95 and $0.98 per share to stockholders during the first quarter of 2024.

Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution

Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company

BOULDER, Colo. , Dec. 6, 2024 /PRNewswire/ -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) ("Fresh Tracks" or "the Company") announced today that a Scheduling Order has been issued by the Court of Chancery of the State of Delaware ("the Court") setting a hearing date of January 17, 2025, for the Court to consider entry of a Consent Judgment agreed to by the Company in the case of David R.

Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company

Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company

Company filed an answer in overall agreement with petition on June 14, 2024 and awaits a hearing date from the Delaware Chancery Court Company filed an answer in overall agreement with petition on June 14, 2024 and awaits a hearing date from the Delaware Chancery Court

Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company

Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th

Stockholders of record on January 11, 2024 who have not yet voted are encouraged to do so by 11:59 p.m. Eastern Time on February 14, 2024

Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th

Fresh Tracks Therapeutics Announces Listing on OTC Pink Market

BOULDER, Colo., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) (“Fresh Tracks” or the “Company”) announced today that the Company's common stock was suspended from trading on The Nasdaq Capital Market at the open of business. Following the suspension, the Company's common stock now is quoted on the OTC Pink market under the same trading symbol, “FRTX.” The Company has withdrawn its appeal of Nasdaq's determination to delist the Company's common stock, which will no longer trade on The Nasdaq Capital Market.

Fresh Tracks Therapeutics Announces Listing on OTC Pink Market

Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th

Common stock expected to begin trading on over-the-counter market following suspension Common stock expected to begin trading on over-the-counter market following suspension

Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th

Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 27, 2023 at 10 a.m. MT

Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 15, 2023 at 10 a.m. MT

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned to November 30, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m.

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

See News Rankings

Charts implemented using Lightweight Charts™